<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="192721">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00583414</url>
  </required_header>
  <id_info>
    <org_study_id>G980198</org_study_id>
    <secondary_id>IRB 3264</secondary_id>
    <nct_id>NCT00583414</nct_id>
  </id_info>
  <brief_title>Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients</brief_title>
  <official_title>Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Matthew Eagleton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the role of abdominal aneurysm and iliac aneurysm
      exclusion using an endovascular prosthesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, non-randomized evaluation of endovascular aneurysm repair in
      high-risk patients. The purpose of this study is to determine whether this endovascular
      prosthesis is safe and effective for the intended use of treating AAA/iliac aneurysm in
      patients who are at high risk for standard aneurysm surgical repair. Up to 400 patients will
      be enrolled at the Cleveland clinic Foundation. Baseline procedures may include angiogram,
      intravascular ultrasound, CT scan, physical exam, blood work and ankle-brachial index. The
      endovascular prosthesis is placed in the operating room under regional or general anesthesia
      and the procedure length is approximately 2-3 hours. Follow up evaluations will be done at 1
      month, 6 months (if clinically necessary), 12 months and yearly, and may include a physical
      exam, CT scan, KUB, ultrasound, blood work, and an ankle-brachial index.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 1998</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from Aneurysm Rupture</measure>
    <time_frame>2 years</time_frame>
    <description>Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <condition>Iliac Aneurysm</condition>
  <condition>Internal Iliac Aneurysm</condition>
  <arm_group>
    <arm_group_label>Endovascular Aneurysm Repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational stent-graft implant to exclude aneurysm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular Aneurysm Repair</intervention_name>
    <description>Endovascular exclusion of aneurysm</description>
    <arm_group_label>Endovascular Aneurysm Repair</arm_group_label>
    <other_name>Cook Zenith</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The aneurysm is &gt;/= 5 cm or larger, or with a high risk of rupture due to its shape,
             history of growth, symptoms, or the presence of a large (&gt;2 cm) iliac aneurysm

          -  Anticipated mortality greater than 10 percent with conventional surgery

          -  Life expectancy greater than 2 years

          -  Suitable arterial anatomy

          -  Absence of systemic disease or allergy that precludes an endovascular repair

          -  Capable of giving informed consent and willingness to comply with the follow-up
             schedule

        Exclusion Criteria:

          -  Pregnancy

          -  History of anaphylactic reaction to contrast material with an inability to properly
             prophylax the patient appropriately

          -  Allergy to stainless steel or polyester

          -  Unwilling to comply with the follow-up schedule

          -  Serious or systemic groin infection

          -  Coagulopathy, other than coumadin therapy

          -  Inability to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J Eagleton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nancy P Simpson</last_name>
    <phone>216-444-9729</phone>
    <email>simpson@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sean Lyden, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sunita Srivastava, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Eagleton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Federico E Parodi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 28, 2017</lastchanged_date>
  <firstreceived_date>December 20, 2007</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cleveland Clinic Foundation</investigator_affiliation>
    <investigator_full_name>Matthew Eagleton</investigator_full_name>
    <investigator_title>Staff</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Iliac Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
